Nutex Health (NASDAQ:NUTX) Issues Quarterly Earnings Results

Key Points

• Nutex Health reported quarterly EPS of $1.61, missing the consensus of $5.56 by $3.95, and revenue of $151.68 million versus an expected $258.82 million, though the company still posted a net margin of 11.62% and a return on equity of 37.44%.
• Shares fell about $11.83 to $93.51 on heavy volume (~382,361) after the report; the stock trades at a P/E of 5.06 with a market cap of $661.1 million, while analysts' average target remains much higher at $252.50 (consensus: Moderate Buy).

Nutex Health (NASDAQ:NUTX - Get Free Report) released its quarterly earnings results on Thursday. The company reported $1.61 EPS for the quarter, missing analysts' consensus estimates of $5.56 by ($3.95), Zacks reports. Nutex Health had a net margin of 11.62% and a return on equity of 37.44%. The firm had revenue of $151.68 million during the quarter, compared to the consensus estimate of $258.82 million.

Nutex Health Stock Performance

NASDAQ:NUTX traded down $11.83 during trading hours on Friday, hitting $93.51. 382,361 shares of the company traded hands, compared to its average volume of 197,719. The company has a current ratio of 3.20, a quick ratio of 3.18 and a debt-to-equity ratio of 0.67. Nutex Health has a twelve month low of $40.67 and a twelve month high of $193.07. The firm has a 50-day moving average of $138.40 and a 200 day moving average of $124.53. The stock has a market capitalization of $661.12 million, a price-to-earnings ratio of 5.06 and a beta of 0.03.

Institutional Investors Weigh In On Nutex Health

Several hedge funds have recently made changes to their positions in NUTX. Deutsche Bank AG lifted its holdings in shares of Nutex Health by 3.9% during the fourth quarter. Deutsche Bank AG now owns 2,633 shares of the company's stock valued at $433,000 after acquiring an additional 98 shares during the period. Russell Investments Group Ltd. increased its position in shares of Nutex Health by 1.4% during the 4th quarter. Russell Investments Group Ltd. now owns 8,706 shares of the company's stock worth $1,433,000 after purchasing an additional 116 shares in the last quarter. First Trust Advisors LP lifted its holdings in Nutex Health by 2.4% during the 4th quarter. First Trust Advisors LP now owns 11,461 shares of the company's stock valued at $1,887,000 after purchasing an additional 272 shares during the last quarter. BNP Paribas Financial Markets boosted its position in Nutex Health by 966.7% in the second quarter. BNP Paribas Financial Markets now owns 320 shares of the company's stock valued at $40,000 after buying an additional 290 shares in the last quarter. Finally, Royal Bank of Canada boosted its position in Nutex Health by 752.4% in the fourth quarter. Royal Bank of Canada now owns 358 shares of the company's stock valued at $59,000 after buying an additional 316 shares in the last quarter. Institutional investors own 5.32% of the company's stock.

Analysts Set New Price Targets

Several brokerages recently commented on NUTX. Weiss Ratings reiterated a "hold (c)" rating on shares of Nutex Health in a report on Monday, December 29th. Wall Street Zen raised Nutex Health from a "buy" rating to a "strong-buy" rating in a research report on Friday, November 28th. Two investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $252.50.

About Nutex Health

Nutex Health, Inc NASDAQ: NUTX is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.